EE Impact

Heel

Germany · Pharma & Healthcare

LeaveRussia detail: Continue Operations

Still operating in Russia

Heel is a German pharmaceutical company founded in 1936 by Hans-Heinrich Reckeweg, specializing in the production of complex homeopathic medicines for humans and animals. The company's name comes from the Latin phrase "Herba est ex luce" ("herb from light"), and its products, such as Traumeel and Engystol, were developed based on the doctor's many years of experience working with patients.

Status last verified 03/08/2026Source checked 22/09/2025Company website ↗LeaveRussia profile ↗

Decision trail

Decision date 09/09/2025 · Reference ↗

Received revenues in Russia in 2022-2024.

Local stats (LeaveRussia)

Assets(RF), mln.USD
44
Capital(RF), mln.USD
23
Revenue(RF), mln.USD
56
Staff(RF), 2021
22

Status history since 2022

  1. 03/08/2026 operating · Imported from KSE LeaveRussia

Possible sanctions matches

Name-based matches against EU/US/UK lists — verify identity before drawing conclusions.

Exposure profile

Full exposure profile is a Professional feature

Energy, transport and commodity exposure, supplier/customer links in the region and sanctioned-party proximity.

Upgrade to Professional
Statuses, logos and narrative notes are compiled from public reporting and the KSE LeaveRussia project. Found an error? See our corrections policy.